These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18000735)

  • 1. Pathophysiology of obesity: why surgery remains the most effective treatment.
    Waseem T; Mogensen KM; Lautz DB; Robinson MK
    Obes Surg; 2007 Oct; 17(10):1389-98. PubMed ID: 18000735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology of weight loss surgery.
    Park CW; Torquati A
    Surg Clin North Am; 2011 Dec; 91(6):1149-61, vii. PubMed ID: 22054145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Why patients lose weight after bariatric operations].
    Bueter M; Seyfried F; Germer CT
    Zentralbl Chir; 2010 Feb; 135(1):28-33. PubMed ID: 20140853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-brain communication: how does it stand after bariatric surgery?
    de Fátima Haueisen Sander Diniz M; de Azeredo Passos VM; Diniz MT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):629-36. PubMed ID: 16912562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of weight loss after gastric bypass and gastric banding.
    Bueter M; Ashrafian H; le Roux CW
    Obes Facts; 2009; 2(5):325-31. PubMed ID: 20057200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.
    Korner J; Inabnet W; Conwell IM; Taveras C; Daud A; Olivero-Rivera L; Restuccia NL; Bessler M
    Obesity (Silver Spring); 2006 Sep; 14(9):1553-61. PubMed ID: 17030966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of obesity.
    Bult MJ; van Dalen T; Muller AF
    Eur J Endocrinol; 2008 Feb; 158(2):135-45. PubMed ID: 18230819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric surgery for morbid obesity.
    Duell PB
    JAMA; 2003 Apr; 289(14):1779; author reply 1779. PubMed ID: 12684352
    [No Abstract]   [Full Text] [Related]  

  • 9. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut and hormones and obesity.
    Wren AM
    Front Horm Res; 2008; 36():165-181. PubMed ID: 18230902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bariatric surgery on gut hormones that alter appetite.
    Pournaras DJ; Le Roux CW
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):508-12. PubMed ID: 20152735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass.
    Christou NV; Look D; McLean AP
    Obes Surg; 2005 Aug; 15(7):1017-23. PubMed ID: 16105400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide YY levels are elevated after gastric bypass surgery.
    Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
    Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
    Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G
    Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
    le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
    Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.
    Pfluger PT; Kampe J; Castaneda TR; Vahl T; D'Alessio DA; Kruthaupt T; Benoit SC; Cuntz U; Rochlitz HJ; Moehlig M; Pfeiffer AF; Koebnick C; Weickert MO; Otto B; Spranger J; Tschöp MH
    J Clin Endocrinol Metab; 2007 Feb; 92(2):583-8. PubMed ID: 17119001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric surgery for severely obese adolescents.
    Sugerman HJ; Sugerman EL; DeMaria EJ; Kellum JM; Kennedy C; Mowery Y; Wolfe LG
    J Gastrointest Surg; 2003 Jan; 7(1):102-108. PubMed ID: 12559191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric metabolic surgery.
    Scopinaro N
    Rozhl Chir; 2014 Aug; 93(8):404-15. PubMed ID: 25230385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.